Sort by:

Charite University Hospital Berlin

9/10 from 95 Votes

high-dose chemotherapy and peripheral blood stem cell autografts (PBSCT) in neuroblastoma (ganglioneyroblastoma) stage 4

The Charité Comprehensive Cancer Center integrates the clinical and research activities for all Charité departments and institutes dealing with Cancer. The director of the Charité Comprehensive Cancer Center is Prof. Dr. med. Ulrich Keilholz.

Duration 50 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Berlin

Price 144734.00